riluzole and Chemical Dependence studies

riluzole and Chemical Dependence

riluzole has been researched along with Chemical Dependence in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research Excerpts

Excerpt	Relevance	Reference
" We evaluated the evidence from randomized controlled trials (RCTs) regarding the use of the glutamatergic drug riluzole in mental illnesses; and conducted preliminary meta-analyses of its effectiveness in treating obsessive-compulsive disorder (OCD) and depression."	5.01	Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis. ( Amelsvoort, TV; de Boer, JN; Hirdes, M; McAlonan, GM; Vingerhoets, C; Zinkstok, JR, 2019)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

1 (50.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
de Boer, JN	1
Vingerhoets, C	1
Hirdes, M	1
McAlonan, GM	1
Amelsvoort, TV	1
Zinkstok, JR	1
Tzschentke, TM	1
Schmidt, WJ	1

Studies

de Boer, JN

Vingerhoets, C

Hirdes, M

McAlonan, GM

Amelsvoort, TV

Zinkstok, JR

Tzschentke, TM

Schmidt, WJ

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia: A Randomized, Group Sequential Adaptive Design, Controlled Clinical Trial[NCT05944510]	Phase 4	72 participants (Anticipated)	Interventional	2023-08-31	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia: A Randomized, Group Sequential Adaptive Design, Controlled Clinical Trial[NCT05944510]

Phase 4

72 participants (Anticipated)

Interventional

2023-08-31

Recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for riluzole and Chemical Dependence

Article	Year
Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis. Psychiatry research, 2019, Volume: 278 Topics: Adult; Autistic Disorder; Depressive Disorder; Female; Humans; Male; Mental Disorders; Neuroprotecti	2019

Article

Year

Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis.

Psychiatry research, 2019, Volume: 278

Topics: Adult; Autistic Disorder; Depressive Disorder; Female; Humans; Male; Mental Disorders; Neuroprotecti

2019

Other Studies

1 other study available for riluzole and Chemical Dependence

Article	Year
Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole. Neuroscience letters, 1998, Feb-13, Volume: 242, Issue:2 Topics: Amphetamine; Animals; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Psychologica	1998

Article

Year

Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole.

Neuroscience letters, 1998, Feb-13, Volume: 242, Issue:2

Topics: Amphetamine; Animals; Brain Chemistry; Central Nervous System Stimulants; Conditioning, Psychologica

1998